Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 200 Total
CVM - Cel-Sci Corp. - Stock Price Chart
TickerCVM [AMEX]
CompanyCel-Sci Corp.
CountryUSA
IndustryBiotechnology
Market Cap76.65MEPS (ttm)-0.68
P/E-EPS this Y-28.77%
Forward P/E-EPS next Y35.11%
PEG-EPS past 5Y17.22%
P/S-EPS next 5Y-
P/B5.61EPS Q/Q25.07%
Dividend-Sales Q/Q-
Insider Own3.20%Inst Own14.10%
Insider Trans3.47%Inst Trans-13.82%
Short Float12.75%EarningsFeb 15/b
Analyst Recom1.00Target Price8.40
Avg Volume360.36K52W Range1.04 - 3.23
May-08-24 04:02PM Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine (MT Newswires) -16.77%
09:00AM CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer (Business Wire)
Apr-23-24 09:00AM CEL-SCI Appoints Mario Gobbo to Its Board of Directors (Business Wire)
Mar-19-24 09:00AM CEL-SCIs LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology (Business Wire)
Mar-06-24 08:45AM CEL-SCI Corporation Issues Letter to Shareholders (Business Wire) +8.07%
Feb-15-24 08:00AM CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results (Business Wire)
Feb-14-24 05:11PM Cel-Sci: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
Feb-13-24 12:00PM CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock (Business Wire)
Feb-09-24 08:30AM CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock (Business Wire) -13.68%
Feb-06-24 09:00AM CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug (Business Wire) +5.48%
DRRX - Durect Corp - Stock Price Chart
TickerDRRX [NASD]
CompanyDurect Corp
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap32.90MEPS (ttm)-1.26
P/E-EPS this Y13.06%
Forward P/E-EPS next Y-6.39%
PEG-EPS past 5Y5.33%
P/S3.85EPS next 5Y15.00%
P/B2.18EPS Q/Q65.40%
Dividend-Sales Q/Q-19.49%
Insider Own6.28%Inst Own23.52%
Insider Trans0.00%Inst Trans-3.45%
Short Float3.24%EarningsMay 13/a
Analyst Recom1.67Target Price6.75
Avg Volume155.93K52W Range0.47 - 7.46
May-07-24 04:30PM DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update (PR Newswire)
Apr-30-24 07:00AM DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis (PR Newswire)
Apr-01-24 02:11PM DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.26%
Mar-27-24 08:53PM DRRX Stock Earnings: Durect Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +5.51%
05:10PM Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:19PM Durect: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (PR Newswire)
Mar-20-24 04:30PM DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update (PR Newswire) +8.47%
Mar-04-24 07:00AM DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET Product Line in U.S. and Canada (PR Newswire)
Feb-07-24 06:48PM DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) -6.69%
NMTC - NeuroOne Medical Technologies Corp - Stock Price Chart
TickerNMTC [NASD]
CompanyNeuroOne Medical Technologies Corp
CountryUSA
IndustryMedical Devices
Market Cap29.04MEPS (ttm)-0.68
P/E-EPS this Y36.15%
Forward P/E-EPS next Y28.92%
PEG-EPS past 5Y23.08%
P/S10.30EPS next 5Y-
P/B6.29EPS Q/Q-30.52%
Dividend-Sales Q/Q-37.72%
Insider Own14.90%Inst Own24.97%
Insider Trans0.65%Inst Trans-0.37%
Short Float1.26%EarningsFeb 13/a
Analyst Recom2.00Target Price2.58
Avg Volume209.07K52W Range0.85 - 2.00
May-10-24 02:43PM NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 (GlobeNewswire)
Apr-10-24 09:00AM NeuroOne CEO Dave Rosa Featured on Bloomberg Technology (GlobeNewswire)
Apr-09-24 09:05AM NeuroOne Announces First Implant of OneRF Ablation Electrodes (GlobeNewswire)
Apr-04-24 09:00AM NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co. (GlobeNewswire)
Mar-26-24 09:00AM NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System (GlobeNewswire) -8.66%
Mar-08-24 12:00PM NeuroOne to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Feb-23-24 05:10PM NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-13-24 04:00PM NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-08-24 03:30PM NeuroOne to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13 (GlobeNewswire)
Dec-14-23 04:15PM NeuroOne Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire) +12.42%
SHOT - Safety Shot Inc - Stock Price Chart
TickerSHOT [NASD]
CompanySafety Shot Inc
CountryUSA
IndustryBeverages - Non-Alcoholic
Market Cap59.06MEPS (ttm)-0.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-43.19%
P/S16.27EPS next 5Y-
P/B6.21EPS Q/Q62.58%
Dividend-Sales Q/Q-85.35%
Insider Own30.30%Inst Own11.03%
Insider Trans0.03%Inst Trans0.71%
Short Float10.78%Earnings-
Analyst Recom1.00Target Price2.76
Avg Volume1.17M52W Range0.26 - 7.50
May-06-24 09:08AM Safety Shot Provides Shareholder Update Highlighting Significant Milestones and Progress (GlobeNewswire)
Apr-09-24 09:03AM Nelk Boys to Partner With Safety Shot to Bring the Recovery & Wellness Drink to Fans and Followers (GlobeNewswire)
Apr-08-24 05:00AM $5 Million No Warrants Private Placement Reaffirms Investor Confidence In Safety Shot Inc. (NASDAQ: SHOT) (News Direct) +7.44%
Apr-05-24 09:30AM Safety Shot Closes $5 Million No Warrant Private Placement Priced At-the-Market (GlobeNewswire)
Mar-20-24 08:30AM Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic Partnership with Launch 33 Brands to Expand Distribution in Los Angeles (GlobeNewswire)
Mar-19-24 04:15PM Safety Shot Wins Lawsuit Against Capybara Research and Igor Appelboom Benzinga Retracts Defamatory Story (GlobeNewswire)
Mar-18-24 08:30AM CEO of Orangetheory Fitness David Long Joins Safety Shot's Board of Directors (GlobeNewswire) +12.50%
Mar-14-24 10:12AM 16 Largest Soda and Soft Drink Companies in The World (Insider Monkey)
Mar-13-24 08:30AM Safety Shot Taps Music and Film Industry Veteran Jordan Schur as New President and Company Board Member (GlobeNewswire)
Mar-12-24 04:15PM Litigation Update - Safety Shot Authorized to Serve Notice of Motion for Default Judgment Upon Capybara Research and Igor Appelboom by Public Disclosure and Press Release (GlobeNewswire) +10.45%
PGNY - Progyny Inc - Stock Price Chart
TickerPGNY [NASD, RUT]
CompanyProgyny Inc
CountryUSA
IndustryHealth Information Services
Market Cap2.66BEPS (ttm)0.61
P/E45.32EPS this Y15.65%
Forward P/E27.95EPS next Y37.38%
PEG3.21EPS past 5Y-
P/S2.40EPS next 5Y14.10%
P/B4.56EPS Q/Q-5.27%
Dividend-Sales Q/Q7.62%
Insider Own13.47%Inst Own87.53%
Insider Trans-5.02%Inst Trans-1.63%
Short Float8.56%EarningsMay 09/a
Analyst Recom1.30Target Price40.67
Avg Volume905.05K52W Range29.44 - 44.95
May-10-24Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-10-24 03:24PM Progyny, Inc. (NASDAQ:PGNY) Q1 2024 Earnings Call Transcript (Insider Monkey) -15.29%
02:01PM Top Midday Decliners (MT Newswires)
01:20PM Progyny Inc (PGNY) Q1 2024 Earnings: Mixed Results Amid Market Challenges (GuruFocus.com)
11:26AM Progyny Shares Drop After Q1 Revenue Miss, KeyBanc Downgrade (MT Newswires)
11:07AM RBC Capital Just Raised Its Price Target on Sweetgreen (SG) Stock (InvestorPlace)
08:53AM Why Is Progyny (PGNY) Stock Down 27% Today? (InvestorPlace)
07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
06:16AM KeyBanc Downgrades Progyny to Sector Weight From Overweight, Cites Questions on Visibility, 'Potential Further Headwinds' (MT Newswires)
May-09-24 08:57PM PGNY Stock Earnings: Progyny Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:38PM Progyny Q1 Adjusted Earnings, Revenue Rise -- Shares Plummet After Hour (MT Newswires)
CORZ - Core Scientific Inc - Stock Price Chart
TickerCORZ [NASD]
CompanyCore Scientific Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap647.12MEPS (ttm)0.11
P/E34.57EPS this Y123.88%
Forward P/E13.59EPS next Y72.48%
PEG-EPS past 5Y-
P/S1.15EPS next 5Y-
P/B-EPS Q/Q2497.75%
Dividend-Sales Q/Q48.60%
Insider Own11.33%Inst Own12.66%
Insider Trans1.98%Inst Trans-
Short Float5.64%EarningsMay 08/a
Analyst Recom1.67Target Price6.75
Avg Volume3.33M52W Range2.61 - 6.10
May-10-24 02:27PM Core Scientific Inc. (CORZ) Reports Remarkable Fiscal Q1 2024 Results, Surpassing Revenue ... (GuruFocus.com) -6.67%
May-09-24 03:51AM Core Scientific Inc (CORZ) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ... (GuruFocus.com) +12.07%
May-08-24 04:10PM Core Scientific Announces Fiscal First Quarter 2024 Results (Business Wire)
May-06-24 09:10AM Core Scientific Announces April 2024 Production and Operations Updates (Business Wire)
May-03-24 04:07PM Trinity Capital Inc. (NASDAQ:TRIN) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:10AM Core Scientific, Inc. Schedules First Quarter Fiscal Year 2024 Earnings Release, Conference Call and Webcast (Business Wire)
Apr-17-24 04:36PM Bitcoins Halving Is Coming. Miners Are Looking for New Ways to Make Money. (The Wall Street Journal)
Apr-16-24 09:10AM Core Scientific to Expand its Denton, Texas Bitcoin Mining Data Center by 72 Megawatts (Business Wire)
Apr-15-24 09:10AM Core Scientific Files Registration Statement for Shares Held by Existing Shareholders (Business Wire) -5.98%
Apr-05-24 09:10AM Core Scientific Announces March 2024 Production and Operations Updates (Business Wire)
ATOS - Atossa Therapeutics Inc - Stock Price Chart
TickerATOS [NASD]
CompanyAtossa Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap186.70MEPS (ttm)-0.24
P/E-EPS this Y-13.54%
Forward P/E-EPS next Y-6.42%
PEG-EPS past 5Y46.61%
P/S-EPS next 5Y-
P/B2.05EPS Q/Q-4.56%
Dividend-Sales Q/Q-
Insider Own0.04%Inst Own12.98%
Insider Trans-33.28%Inst Trans-14.05%
Short Float9.14%EarningsApr 01/a
Analyst Recom1.00Target Price4.67
Avg Volume1.84M52W Range0.62 - 2.31
May-07-24 08:30AM Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines (GlobeNewswire)
Apr-30-24 10:30AM As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response (PR Newswire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
08:30AM Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen (GlobeNewswire)
Apr-15-24 08:30AM Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO ) in Women with ER+/HER2- Breast Cancer (GlobeNewswire)
Apr-11-24 10:10AM Atossa (ATOS) Reports Positive Results From EVANGELINE Study (Zacks)
08:30AM Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference (GlobeNewswire)
Apr-09-24 11:59AM Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen (GlobeNewswire) +5.14%
Apr-01-24 10:53PM ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023 (InvestorPlace) +11.11%
04:00PM Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
SEPA - SEP Acquisition Corp - Stock Price Chart
TickerSEPA [NASD]
CompanySEP Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap59.23MEPS (ttm)-0.41
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B5.94EPS Q/Q-284.37%
Dividend-Sales Q/Q-
Insider Own91.15%Inst Own5.00%
Insider Trans0.00%Inst Trans-
Short Float0.58%Earnings-
Analyst Recom-Target Price-
Avg Volume5.60K52W Range8.20 - 17.00
Jan-22-24 07:59AM SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA) (GlobeNewswire)
Aug-23-23 04:30PM SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company (GlobeNewswire)
SNAX - Stryve Foods Inc - Stock Price Chart
TickerSNAX [NASD]
CompanyStryve Foods Inc
CountryUSA
IndustryPackaged Foods
Market Cap5.53MEPS (ttm)-37.24
P/E-EPS this Y21.53%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.31EPS next 5Y30.00%
P/B2.78EPS Q/Q-3.61%
Dividend-Sales Q/Q-46.62%
Insider Own58.33%Inst Own7.15%
Insider Trans1.48%Inst Trans-75.55%
Short Float4.87%EarningsApr 01/a
Analyst Recom1.00Target Price4.00
Avg Volume57.23K52W Range1.04 - 12.75
Apr-01-24 08:53PM SNAX Stock Earnings: Stryve Foods Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:20PM Stryve Foods, Inc. Reports Full Year Fiscal 2023 Results (GlobeNewswire)
Mar-27-24 03:58PM Stryve Foods, Inc. Announces Timing of Fiscal Year 2023 Results (GlobeNewswire) +8.73%
Mar-20-24 09:16AM Stryve and Bitcoin BTC Sweepstakes Launches Today (GlobeNewswire)
Mar-12-24 09:00AM Stryve Foods is Proud to Announce New and Improved Retail Packaging Showcasing Thinly Sliced Steak: A Game-Changer in Snacking (GlobeNewswire)
Mar-05-24 02:09PM Stryve and Bitcoin Creative Strategies to Generate Consumer Awareness, Drive Trial, and Build Loyalty BTC Sweepstakes Announced (GlobeNewswire)
Feb-01-24 09:15AM Stryve Foods Expands Distribution Footprint, Now Available at Leading Retailers Across the Nation (GlobeNewswire)
Dec-13-23 08:30AM Stryve Foods Announces Strategic Partnership with Acosta Group to Drive Retail Sales and Distribution Growth (GlobeNewswire)
Nov-28-23 08:15AM Stryve Foods Announces Major Distribution Expansion into Leading Retailers Across the United States (GlobeNewswire)
Nov-20-23 07:45AM Stryve Expands Distribution of Vacadillos, Now Available Nationwide at Albertsons Companies Inc. Stores (GlobeNewswire) -6.25%
KUKE - Kuke Music Holding Ltd ADR - Stock Price Chart
TickerKUKE [NYSE]
CompanyKuke Music Holding Ltd ADR
CountryChina
IndustryEntertainment
Market Cap49.46MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B7.10EPS Q/Q175.87%
Dividend-Sales Q/Q-41.84%
Insider Own-Inst Own0.02%
Insider Trans-Inst Trans-22.33%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume61.25K52W Range0.42 - 4.07
Apr-18-24 10:30AM KUKE Enters Strategic Partnership with China National Youth Palace Association (PR Newswire) -11.08%
Mar-14-24 10:00AM Kuke Music Establishes R&D Center in Guangzhou (PR Newswire) +5.06%
Feb-22-24 10:01AM Enjoy Your Drive with Music (PR Newswire)
Dec-27-23 04:05PM Kuke Reports First Half of 2023 Unaudited Financial Results (GlobeNewswire)
Sep-29-23 01:02PM Naxos China Dedicated to promoting Chinese Local Music and Artists, Opening a New International Stage (GlobeNewswire)
Sep-26-23 09:24AM Kuke Music Receives Continued Listing Standard Notice from the NYSE (GlobeNewswire) +13.04%
Jul-18-23 06:10AM Lacklustre Performance Is Driving Kuke Music Holding Limited's (NYSE:KUKE) 28% Price Drop (Simply Wall St.) -7.96%
Jun-12-23 09:53AM KUKE MUSIC HAS ESTABLISHED A BRAND-NEW OPERATING CENTER IN WUHAN, AIMING TO OPTIMIZE COST EFFICIENCY (GlobeNewswire) -15.88%
May-18-23 07:06AM Kuke Music Holding Full Year 2022 Earnings: CN¥30.19 loss per share (vs CN¥2.03 loss in FY 2021) (Simply Wall St.)
Apr-03-23 09:00AM Kuke Music Regains Compliance with NYSE Continued Listing Criterion (PR Newswire)
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.